Prevalence of metabolic syndrome according to ATPIII and IDF criteria in the Iranian population

Bahareh AbtaeiNaeini; Rahimeh Skandarian; Ali Rashidi; Mohammad Ebrahim Khamse; Mojtaba Malek; Raheb Ghorbani

Koomesh

Journal of Semnan University of Medical Sciences

Current Issue Archive In Press Accepted Manuscripts Search

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Publication Malpractice Statement Support Contact Us Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Prevalence of metabolic syndrome according to ATPIII and IDF criteria in the Iranian population

Authors:

Bahareh AbtaeiNaeini,

Rahimeh Skandarian,

Ali Rashidi,

Mohammad Ebrahim Khamse,

Mojtaba Malek^,*,

Raheb Ghorbani

Koomesh:Vol. 14, issue 1; 65-75

Published online:Sep 25, 2012

Article type:Research Article

Received:Jan 02, 2012

Accepted:Apr 02, 2012

How to Cite:Bahareh AbtaeiNaeiniRahimeh SkandarianAli RashidiMohammad Ebrahim KhamseMojtaba MalekRaheb Ghorbaniet al.Prevalence of metabolic syndrome according to ATPIII and IDF criteria in the Iranian population.14(1):e152550.

Abstract

Introduction: Metabolic syndrome is a collection of metabolic disorders that increase the risk of cardiovascular diseases (CVD) and diabetes. Metabolic syndrome is characterized by abdominal obesity, hypertriglyceridemia, low HDL level, hyperglycemia and HTN. With regard to the development of CVD disease in recent years, the present study was completed to determine the degree of metabolic syndrome prevalence in the adult population of Semnan province. Materials and Methods: This epidemiological cross-sectional study was carried out in the province of Semnan (Iran) on 3799 individuals between 30 and 70 years of age. In the study, multi-stage individuals were randomly selected from urban and rural environments and the prevalence of metabolic syndrome was determined according to ATPIII and IDF criteria. Results: The prevalence of metabolic syndrome according to ATPIII and IDF was 28.5% and 35.8% respectively, and increased with age in both sexes. The highest degree of prevalence was seen in the above-60-years age group. The Prevalence of metabolic syndrome was significantly higher in women on basis of both definitions it was higher among non-smokers on basis of the IDF definition (P

Keywords

comments